Full Press Release Details
ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that it has filed a class action lawsuit against Fulcrum Therapeutics, Inc. (“Fulcrum” or the “Company”) (NASDAQ: FULC). The lawsuit alleges Fulcrum made materially false and/or misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations, and compliance policies, including: (i) the preclinical data submitted in support of the Company’s drug candidate, FTX-6058, showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; and (iii) accordingly, the Company had overstated FTX-6058’s clinical and/or commercial prospects.
If you bought shares of Fulcrum between March 3, 2022 and March 8, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website https://holzerlaw.com/case/fulcrum/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is June 27, 2023.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
(888) 508-6832 (toll-free)